BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20410905)

  • 1. Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis.
    Sharma R; Hudak ML; Tepas JJ; Wludyka PS; Teng RJ; Hastings LK; Renfro WH; Marvin WJ
    J Perinatol; 2010 Dec; 30(12):786-93. PubMed ID: 20410905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
    Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
    Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
    J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal indomethacin is more likely associated with spontaneous intestinal perforation rather than NEC.
    Gordon PV; Swanson JR; Clark R
    Am J Obstet Gynecol; 2008 Jun; 198(6):725; author reply 725-6. PubMed ID: 18538165
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation.
    Attridge JT; Clark R; Gordon PV
    J Perinatol; 2006 Nov; 26(11):667-70. PubMed ID: 17024144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin and recurrent ileal perforations in a preterm infant.
    Giacoia GP; Azubuike K; Taylor JR
    J Perinatol; 1993; 13(4):297-9. PubMed ID: 8410386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
    Dollberg S; Lusky A; Reichman B
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining phenobarbital and indomethacin to improve early neonatal outcomes in the extremely low birth weight infant.
    Okah FA; Mundy DC; Ekekezie II
    Am J Perinatol; 2005 Jan; 22(1):11-7. PubMed ID: 15668839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants.
    Lee J; Rajadurai VS; Tan KW; Wong KY; Wong EH; Leong JY
    Pediatrics; 2003 Aug; 112(2):345-50. PubMed ID: 12897285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure.
    Attridge JT; Clark R; Walker MW; Gordon PV
    J Perinatol; 2006 Feb; 26(2):93-9. PubMed ID: 16319937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin and retinopathy of prematurity.
    Darlow BA
    J Pediatr; 2009 Nov; 155(5):763. PubMed ID: 19840629
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience.
    Pietz J; Achanti B; Lilien L; Stepka EC; Mehta SK
    Pediatrics; 2007 Jan; 119(1):e164-70. PubMed ID: 17145901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal dexamethasone for lung disease of prematurity.
    Gordon PV
    N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218578
    [No Abstract]   [Full Text] [Related]  

  • 17. New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations.
    Attridge JT; Clark R; Walker MW; Gordon PV
    J Perinatol; 2006 Mar; 26(3):185-8. PubMed ID: 16493433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attridge et al. present an analysis of a complex data set, which offers important confirmation of the differences between the clinical presentation of spontaneous intestinal perforations (SIP) and surgical necrotizing enterocolitis (NEC).
    Bloom BT
    J Perinatol; 2006 Jun; 26(6):384; author reply 384-6. PubMed ID: 16724082
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants.
    Tatli MM; Kumral A; Duman N; Demir K; Gurcu O; Ozkan H
    Acta Paediatr; 2004 Jul; 93(7):999-1001. PubMed ID: 15303820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates.
    Paquette L; Friedlich P; Ramanathan R; Seri I
    J Perinatol; 2006 Aug; 26(8):486-92. PubMed ID: 16791261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.